Nrx pharmaceuticals (nasdaq:nrxp) appoints michael abrams as chief financial officer

Industry veteran with extensive experience in key areas of focus interim-cfo richard narido to focus on hope therapeutics acquisition opportunities wilmington, del., nov. 18, 2024 /prnewswire/ -- nrx pharmaceuticals, inc. (nasdaq: nrxp) ("nrx pharmaceuticals", the "company"), a clinical-stage biopharmaceutical company, today announced it has appointed michael abrams as its permanent chief financial officer.
NRXP Ratings Summary
NRXP Quant Ranking